Keywords: ضخامت زیرفایل مرکزی; BRVO; branch retinal vein occlusion; CAT; cube average thickness; CRVO; central retinal vein occlusion; CST; central subfield thickness; CV; cube volume; EZ; ellipsoid zone; HRVO; Hemiretinal vein occlusion; ME; macular edema; RPE; retinal pigment epithel
مقالات ISI ضخامت زیرفایل مرکزی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ضخامت زیرفایل مرکزی; AMD; age-related macular degeneration; CAT; cube average thickness; CATT; Comparison of AMD Treatments Trial; CNV; choroidal neovascularization; CST; central subfield thickness; MA; macular atrophy; MV; macular volume; nAMD; neovascular age-related macula
Keywords: ضخامت زیرفایل مرکزی; AE; adverse event; BCVA; best-corrected visual acuity; CI; confidence interval; CRC; central reading center; CSC; central serous chorioretinopathy; CSFT; central subfield thickness; CSFV; central subfield volume; DME; diabetic macular edema; ETDRS; Early
Keywords: ضخامت زیرفایل مرکزی; AE; adverse event; AMD; age-related macular degeneration; ANOVA; analysis of variance; BCVA; best-corrected visual acuity; CF; color fundus photography; CI; confidence interval; CSFT; central subfield thickness; ETDRS; Early Treatment Diabetic Retinopathy
Keywords: ضخامت زیرفایل مرکزی; AE; adverse event; BCVA; best-corrected visual acuity; BRVO; branch retinal vein occlusion; CI; confidence interval; CRC; Central Reading Center; CSFT; central subfield thickness; ETDRS; Early Treatment Diabetic Retinopathy Study; LS; least squares; OCT;
Keywords: ضخامت زیرفایل مرکزی; AV; arteriovenous; BCVA; best-corrected visual acuity; BRAVO; RanibizumaB for the treatment of macular edema following bRAnch retinal Vein Occlusion; BRVO; branch retinal vein occlusion; BVOS; Branch Vein Occlusion Study; CFT; central foveal thickness; CP
Keywords: ضخامت زیرفایل مرکزی; BRVO; branch retinal vein occlusion; CRVO; central retinal vein occlusion; CST; central subfield thickness; DR; diabetic retinopathy; DRIL; disorganization of the retinal inner layers; ETDRS; Early Treatment Diabetic Retinopathy Study; EZ; ellipsoid zone;
Keywords: ضخامت زیرفایل مرکزی; CI; confidence interval; CPT; Current Procedural Terminology; CST; central subfield thickness; ICD-9-CM; International Classification of Diseases, Ninth Revision, Clinical Modification; IOP; intraocular pressure; NSAID; nonsteroidal anti-inflammatory drug
Keywords: ضخامت زیرفایل مرکزی; BCVA; best-corrected visual acuity; CFT; central foveal thickness; CST; central subfield thickness; DME; diabetic macular edema; ETDRS; Early Treatment Diabetic Retinopathy Study; OCT; optical coherence tomography; OR; odds ratio; PRP; panretinal photocoa
Keywords: ضخامت زیرفایل مرکزی; AMD; age-related macular degeneration; BCVA; best-corrected visual acuity; BRVO; branch retinal vein occlusion; CRVO; central retinal vein occlusion; CST; central subfield thickness; OCT; optical coherence tomography; PRN; pro re nata; RBZ; ranibizumab; R
Keywords: ضخامت زیرفایل مرکزی; AE; adverse event; BCVA; best-corrected visual acuity; BRAVO; Treatment of Macular Edema following Branch Retinal Vein Occlusion: Evaluation of Efficacy and Safety; BRVO; branch retinal vein occlusion; CRUISE; Treatment of Macular Edema following Central
Outcomes of Intraoperative OCT-Assisted Epiretinal Membrane Surgery from the PIONEER Study
Keywords: ضخامت زیرفایل مرکزی; CFT; central foveal thickness; COST; cone outer segment tips (i.e., see IZ); CST; central subfield thickness; ERM; epiretinal membrane; EZ; ellipsoid zone; ICG; indocyanine green; ILM; internal limiting membrane; iOCT; intraoperative OCT; IZ; interdigitat
Baseline Factors Affecting Changes in Diabetic Retinopathy Severity Scale Score After Intravitreal Aflibercept or Laser for Diabetic Macular Edema
Keywords: ضخامت زیرفایل مرکزی; BCVA; best-corrected visual acuity; BMI; body mass index; CST; central subfield thickness; DME; diabetic macular edema; DR; diabetic retinopathy; DRSS; Diabetic Retinopathy Severity Scale; HbA1c; hemoglobin A1c; IAI; intravitreal aflibercept injection; VE
Efficacy of Ranibizumab in Eyes with Diabetic Macular Edema and Macular Nonperfusion in RIDE and RISE
Keywords: ضخامت زیرفایل مرکزی; BCVA; best-corrected visual acuity; CST; central subfield thickness; DA; disc area; DME; diabetic macular edema; DR; diabetic retinopathy; ETDRS; Early Treatment for Diabetic Retinopathy Study; FA; fluorescein angiogram; FAZ; foveal avascular zone; MNP; m
A Prospective Randomized Comparative Dosing Trial of Ranibizumab in Bevacizumab-Resistant Diabetic Macular Edema
Keywords: ضخامت زیرفایل مرکزی; BCVA; best-corrected visual acuity; CST; central subfield thickness; DME; diabetic macular edema; ETDRS; Early Treatment Diabetic Retinopathy Study; PRN; pro re nata; REACT; Safety and Efficacy of Intravitreal Ranibizumab for Diabetic Macular Edema Previo
Outcomes of Diabetic Macular Edema Eyes with Limited Early Response in the VISTA and VIVID Studies
Keywords: ضخامت زیرفایل مرکزی; BCVA; best-corrected visual acuity; CI; confidence interval; CST; central subfield thickness; DME; diabetic macular edema; DRSS; Diabetic Retinopathy Severity Scale; IAI; intravitreal aflibercept injection; LS; least square; NPDR; nonproliferative diabeti
Suprachoroidal Triamcinolone Acetonide for Retinal Vein Occlusion: Results of the Tanzanite Study
Keywords: ضخامت زیرفایل مرکزی; BCVA; best-corrected visual acuity; BRVO; branch retinal vein occlusion; CLS-TA; triamcinolone acetonide; CRVO; central retinal vein occlusion; CST; central subfield thickness; ETDRS; Early Treatment Diabetic Retinopathy Study; HRVO; hemiretinal vein occl
Sustained Benefits from Ranibizumab for Central Retinal Vein Occlusion with Macular Edema: 24-Month Results of the CRYSTAL Study
Keywords: ضخامت زیرفایل مرکزی; AE; adverse event; BCVA; best-corrected visual acuity; CFT; central foveal thickness; CRC; central reading center; CRVO; central retinal vein occlusion; CSFT; central subfield thickness; ETDRS; Early Treatment Diabetic Retinopathy Study; FAS; full analysi
Safety and Efficacy of Adalimumab in Patients with Noninfectious Uveitis in an Ongoing Open-Label Study: VISUAL III
Keywords: ضخامت زیرفایل مرکزی; AE; adverse event; BCVA; best-corrected visual acuity; CI; confidence interval; CST; central subfield thickness; ETDRS; Early Treatment Diabetic Retinopathy Study; ITT; intent to treat; LOCF; last observation carried forward; MRI; magnetic resonance imagi
A 24-Month Evaluation of Aflibercept for Wet Age-Related Macular Degeneration in Patients Previously Receiving Ranibizumab or Bevacizumab
Keywords: ضخامت زیرفایل مرکزی; AE; adverse event; AMD; age-related macular degeneration; BCVA; best-corrected visual acuity; CST; central subfield thickness; IAI; intravitreal aflibercept; IRF; intraretinal fluid; PED; pigment epithelial detachment; PRN; pro re nata; SRF; subretinal fl
Phase I Trial of Anti-Vascular Endothelial Growth Factor/Anti-angiopoietin 2 Bispecific Antibody RG7716 for Neovascular Age-Related Macular Degeneration
Keywords: ضخامت زیرفایل مرکزی; AE; adverse event; AMD; age-related macular degeneration; BCVA; best-corrected visual acuity; CNV; choroidal neovascularization; CST; central subfield thickness; FcRn; neonatal Fc receptor; IgG; immunoglobulin G; IOP; intraocular pressure; MD; multiple do
Intravitreal Aflibercept Injection in Diabetic Macular Edema Patients with and without Prior Anti-Vascular Endothelial Growth Factor Treatment
Keywords: ضخامت زیرفایل مرکزی; BCVA; best-corrected visual acuity; CST; central subfield thickness; DME; diabetic macular edema; DRSS; Diabetic Retinopathy Severity Scale; ETDRS; Early Treatment Diabetic Retinopathy Study; IAI; intravitreal aflibercept injection; SD; standard deviation
Predictors of Outcome in Patients with Neovascular Age-Related Macular Degeneration Switched from Ranibizumab to 8-Weekly Aflibercept
Keywords: ضخامت زیرفایل مرکزی; AMD; age-related macular degeneration; CI; confidence interval; CST; central subfield thickness; ERM; epiretinal membrane; HF; hyperreflective foci; IRF; intraretinal fluid; nAMD; neovascular age-related macular degeneration; OCT; optical coherence tomogr
Enhanced Benefit in Diabetic Macular Edema from AKB-9778 Tie2 Activation Combined with Vascular Endothelial Growth Factor Suppression
Keywords: ضخامت زیرفایل مرکزی; AE; adverse event; BCVA; best-corrected visual acuity; BID; twice per day; CST; central subfield thickness; DME; diabetic macular edema; DRSS; Diabetic Retinopathy Severity Score; ETDRS; Early Treatment Diabetic Retinopathy Study; NO; nitric oxide; SD OCT
Single-Chain Antibody Fragment VEGF Inhibitor RTH258 for Neovascular Age-Related Macular Degeneration: A Randomized Controlled Study
Keywords: ضخامت زیرفایل مرکزی; AE; adverse event; AMD; age-related macular degeneration; AUC; area under the curve; BCVA; best-corrected visual acuity; CI; confidence interval; CSFT; central subfield thickness; ITT; intent-to-treat; MFD; maximum feasible dose; PBT; post-baseline therap
Intravitreal Aflibercept for Diabetic Macular Edema
Keywords: ضخامت زیرفایل مرکزی; aLOCF; last observation carried forward, including measurements after additional or PRN treatment was given; AMD; age-related macular degeneration; BCVA; best-corrected visual acuity; CST; central subfield thickness; DME; diabetic macular edema; DRSS; Dia
Individualized Ranibizumab Regimen Driven by Stabilization Criteria for Central Retinal Vein Occlusion: Twelve-Month Results of the CRYSTAL Study
Keywords: ضخامت زیرفایل مرکزی; AE; adverse event; BCVA; best-corrected visual acuity; CRC; central reading center; CRVO; central retinal vein occlusion; CSFT; central subfield thickness; ETDRS; Early Treatment Diabetic Retinopathy Study; EU SmPC; 2011 Lucentis European Union Summary of
Therapies for Macular Edema Associated with Central Retinal Vein Occlusion
Keywords: ضخامت زیرفایل مرکزی; BCVA; best-corrected visual acuity; BRVO; branch retinal vein occlusion; CFT; central foveal thickness; COPERNICUS; Vascular Endothelial Growth Factor [VEGF] Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion [CRVO]; CRUISE;
Treatment of Diabetic Macular Edema with an Inhibitor of Vascular Endothelial-Protein Tyrosine Phosphatase That Activates Tie2
Keywords: ضخامت زیرفایل مرکزی; Ang1; angiopoietin 1; Ang2; angiopoietin 2; BCVA; best-corrected visual acuity; CST; central subfield thickness; DME; diabetic macular edema; VEGF; vascular endothelial growth factor; VE-PTP; vascular endothelial-protein tyrosine phosphatase;